Curation NME NAXE
2 + 3 = 5 / 18
Genetic evidence
Total: 2
Category | Type | Citation | Score | Details |
|---|---|---|---|---|
Singular Evidence | Probands | 1.5 | One affected proband (Pt2359, Family A) with NAXE-related mitochondrial encephalopathy carried a biallelic ~200-unit GGGCC repeat expansion in the NAXE promoter. Family testing showed maternal heterozygosity and proband homozygosity due to maternal chromosome 1 UPD; other explanatory variants were not identified. | |
Collective Evidence | Computational | 0.5 | Targeted ExpansionHunter detected the homozygous NAXE promoter GGGCC expansion in Pt2359 and a mild heterozygous expansion signal in the mother; de novo tools ExpansionHunter Denovo and STRling did not detect the expansion. Cohort/TR-gnomAD data support rarity of alleles outside the common short-repeat range. |
Experimental evidence
Total: 3
Category | Type | Citation | Score | Details |
|---|---|---|---|---|
Function | Biochemical function | 0.5 | Gene-level: NAXE encodes NAD(P)HX epimerase in the NAD(P)HX repair system, and loss of this enzyme compromises mitochondrial function; this supports disease-relevant biochemical function but is not tandem-repeat/locus-specific. | |
Function | Regulatory impact | 1.5 | TR-specific: the biallelic NAXE promoter GGGCC expansion was associated with markedly reduced NAXE RNA, reduced nascent promoter transcripts by NET-CAGE, and CpG hypermethylation at and downstream of the repeat, supporting transcriptional suppression. | |
Functional Alteration | Patient cells | 1 | Patient-derived fibroblasts from Pt2359 showed disease-relevant functional alteration, including reduced oxygen consumption and reduced oxidative phosphorylation complex II/II+III activity, with reduced NAXE RNA/protein in the same patient-cell context. |